Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMin Su

About this trial

Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after stroke. This study aims to utilize machine learning technology to integrate multi-dimensional indicators of patients with ischemic stroke, establish a risk prediction model for PSD, and assist in early, accurate, and individualized assessment of PSD risk in clinical practice.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with acute ischemic stroke;

Admission within 7 days of symptom onset;

The patient and/or the family members sign a written informed consent form.

Disqualifiers

Confusion of consciousness,severe cognitive impairment, etc

Individuals with a history of depression, schizophrenia, bipolar disorder, etc;

Individuals unable to participate in neuropsychological examinations due to hearing im pairments, lack of coordination, or neurological deficits, including se vere aphasia.

Trial population

Acute ischemic stroke patients who may develop post-stroke depression

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Group patients based on whether they have been diagnosed with PSD.

    Diagnostic test

    Group patients based on whether they have been diagnosed with PSD.

Treatment groups

488 Participants
are divided into 2 treatment groups
Group A: The group of PSD1 intervention
Group B: NPSD1 intervention

Trial outcomes

Primary outcomes

1

The number of post-stroke depression (PSD) that occurs 3 months after stroke

Time frame
3 months after stroke

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Min Su

Lead sponsor

First Affiliated Hospital of Chongqing Medical University

Sponsor institution

Chongqing Traditional Chinese Medicine Hospital

Collaborator